Last reviewed · How we verify
Jinfukang Koufuye — Competitive Intelligence Brief
phase 3
Immunology / General Wellness
Small molecule
Live · refreshed every 30 min
Target snapshot
Jinfukang Koufuye (Jinfukang Koufuye) — lihegen. Jinfukang Koufuye is a traditional Chinese medicine oral liquid formulation designed to support immune function and general wellness.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Jinfukang Koufuye TARGET | Jinfukang Koufuye | lihegen | phase 3 |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Jinfukang Koufuye CI watch — RSS
- Jinfukang Koufuye CI watch — Atom
- Jinfukang Koufuye CI watch — JSON
- Jinfukang Koufuye alone — RSS
Cite this brief
Drug Landscape (2026). Jinfukang Koufuye — Competitive Intelligence Brief. https://druglandscape.com/ci/jinfukang-koufuye. Accessed 2026-05-16.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab